生物
肿瘤微环境
癌症免疫疗法
免疫系统
免疫检查点
背景(考古学)
免疫疗法
免疫
癌症
癌症研究
细胞代谢
免疫学
细胞
遗传学
古生物学
作者
Jackie E. Bader,Kelsey Voss,Jeffrey C. Rathmell
出处
期刊:Molecular Cell
[Elsevier BV]
日期:2020-06-01
卷期号:78 (6): 1019-1033
被引量:771
标识
DOI:10.1016/j.molcel.2020.05.034
摘要
The growing field of immune metabolism has revealed promising indications for metabolic targets to modulate anti-cancer immunity. Combination therapies involving metabolic inhibitors with immune checkpoint blockade (ICB), chemotherapy, radiation, and/or diet now offer new approaches for cancer therapy. However, it remains uncertain how to best utilize these strategies in the context of the complex tumor microenvironment (TME). Oncogene-driven changes in tumor cell metabolism can impact the TME to limit immune responses and present barriers to cancer therapy. These changes also reveal opportunities to reshape the TME by targeting metabolic pathways to favor immunity. Here we explore current strategies that shift immune cell metabolism to pro-inflammatory states in the TME and highlight a need to better replicate physiologic conditions to select targets, clarify mechanisms, and optimize metabolic inhibitors. Unifying our understanding of these pathways and interactions within the heterogenous TME will be instrumental to advance this promising field and enhance immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI